imatinib mesylate has been researched along with Day Blindness in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Chan, CK; Mohamed, S; Szeto, SK; Tsang, CW | 1 |
Chopra, Y; Grover, AK; Ramzan, M; Yadav, SP | 1 |
Auffarth, GU; Kaiser, D; Khoramnia, R; Marx, S; Scheuerle, A; Sel, S; Tandogan, T | 1 |
Ghosh, B; Goel, N; Pangtey, B; Raina, UK; Thakar, M | 1 |
Arakawa, A; Kami, M; Kato, D; Kishi, Y; Kusumi, E; Miyakoshi, S; Morinaga, S; Murashige, N; Muto, Y; Taniguchi, S; Ueyama, J; Yuji, K | 1 |
Anupama, G; Attili, VS; Bapsy, PP; Govind Babu, K | 1 |
6 other study(ies) available for imatinib mesylate and Day Blindness
Article | Year |
---|---|
Massive retinal infiltrates as the presenting sign of chronic myeloid leukemia: Clinical and imaging features of leukemic retinopathy.
Topics: Animals; Chronic Disease; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Retina; Retinal Diseases; Retinal Hemorrhage; Vision Disorders | 2023 |
Isolated bilateral uveitis in child with hypereosinophilic syndrome.
Topics: Benzamides; Child; Female; Glucocorticoids; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Piperazines; Prednisolone; Protein Kinase Inhibitors; Pyrimidines; Treatment Outcome; Uveitis; Vision Disorders | 2014 |
[Sudden bilateral decreased vision in a 14-year-old boy].
Topics: Adolescent; Emergency Service, Hospital; Fundus Oculi; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Retinal Hemorrhage; Tomography, Optical Coherence; Vision Disorders; Vision, Binocular; Vision, Low | 2017 |
Chronic myeloid leukemia presenting with bilateral central retinal vein occlusion and massive retinal infiltrates.
Topics: Adolescent; Allopurinol; Antineoplastic Agents; Benzamides; Bone Marrow; Drug Therapy, Combination; Humans; Hydroxyurea; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemic Infiltration; Male; Piperazines; Proto-Oncogene Proteins c-bcr; Pyrimidines; Retina; Retinal Neoplasms; Retinal Vein Occlusion; Vision Disorders; Visual Acuity | 2012 |
Visual disturbance due to retinal edema as a complication of imatinib.
Topics: Adult; Antineoplastic Agents; Benzamides; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Papilledema; Piperazines; Pyrimidines; Vision Disorders | 2004 |
Imatinib-induced optic neuritis in a patient of chronic myeloid leukemia.
Topics: Antineoplastic Agents; Benzamides; Glucocorticoids; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Optic Neuritis; Piperazines; Prednisolone; Pyrimidines; Treatment Outcome; Vision Disorders | 2007 |